Tff Pharmaceuticals Inc (TFFP)

$0.07 -0.10 (-60.05%)
Market Cap 289,000.00
Revenue (ttm) 730,000.00
Net Income (ttm) -21.24M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,909.59%
Debt to Equity Ratio 0.00
Volume 13,285,400
Avg Vol 2,078,708
Day's Range N/A - N/A
Shares Out 4.44M
Stochastic %K 1%
Beta 1.07
Analysts Strong Buy
Price Target $30.00
A_Aron1990
A_Aron1990 May. 21 at 12:34 PM
$TFFP for fucks sake how long this shit take to be removed
1 · Reply
frenulum1
frenulum1 Apr. 23 at 7:03 PM
$TFFP imagine being a promoter of this stock?
0 · Reply
YesterdayRecords
YesterdayRecords Apr. 2 at 4:53 AM
$TFFP How much longer will this be locked up? I’d like to sell and be done
0 · Reply
G1992
G1992 Feb. 3 at 4:42 PM
$TFFP sup with this trash thought we had to hear about vote count last week
1 · Reply
Faroose
Faroose Jan. 25 at 1:20 PM
$FMST breaking past key technical resistance, high RVOL, low float, and insider buying making it unstoppable $TFFP moving $FLYE soaring $SVUHF climbing
1 · Reply
Pumptie
Pumptie Jan. 20 at 5:13 PM
$ABVE bottom chart low floats have been killer. $NUKK was insane. $TFFP WW $HMR ww $TNXP was huge call out. Great play again This is next. Looking for 100% to 200% easy
2 · Reply
Pumptie
Pumptie Jan. 20 at 5:02 PM
$ABVE this has huge potential all over it. Alot of whales taking about it. Im in. $TFFP going MSTR GOING TO 500
0 · Reply
A_Aron1990
A_Aron1990 Jan. 17 at 1:36 PM
$TFFP just go away you POS
0 · Reply
YesterdayRecords
YesterdayRecords Dec. 26 at 10:08 PM
Man, I’m sick of having to keep seeing this train wreck… $TFFP is now like that one shitty ex- who just lingers around not going away…
0 · Reply
Winner4Ever
Winner4Ever Dec. 26 at 8:13 PM
$TFFP what is going on?
0 · Reply
Latest News on TFFP
TFF Pharmaceuticals Announces Delisting from Nasdaq and Potential SEC Deregistration

Feb 6, 2025, 4:05 PM EST - 4 months ago

TFF Pharmaceuticals Announces Delisting from Nasdaq and Potential SEC Deregistration

TFF Pharmaceuticals Announces It Will Wind Down Operations

Nov 14, 2024, 4:15 PM EST - 7 months ago

TFF Pharmaceuticals Announces It Will Wind Down Operations

TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID

Sep 11, 2024, 7:00 AM EDT - 9 months ago

TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID

TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization

Sep 10, 2024, 7:00 AM EDT - 10 months ago

TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization

TFF Pharmaceuticals Provides Continued Positive Outcomes from Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection

Aug 6, 2024, 8:00 AM EDT - 11 months ago

TFF Pharmaceuticals Provides Continued Positive Outcomes from Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection

TFF Pharmaceuticals Engages Outcome Capital As a Strategic Advisor for Evaluating Partnership and Licensing Opportunities

Jun 26, 2024, 7:00 AM EDT - 1 year ago

TFF Pharmaceuticals Engages Outcome Capital As a Strategic Advisor for Evaluating Partnership and Licensing Opportunities

TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing

May 23, 2024, 7:00 AM EDT - 1 year ago

TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing

TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing

May 20, 2024, 7:00 AM EDT - 1 year ago

TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing

TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection

May 15, 2024, 7:00 AM EDT - 1 year ago

TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection

TFF Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update

May 14, 2024, 4:05 PM EDT - 1 year ago

TFF Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update

TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering

May 1, 2024, 5:07 PM EDT - 1 year ago

TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering

TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering

Apr 29, 2024, 8:00 PM EDT - 1 year ago

TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering

TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting

Apr 29, 2024, 10:00 AM EDT - 1 year ago

TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting

TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions

Apr 15, 2024, 7:00 AM EDT - 1 year ago

TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions

TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 28, 2024, 4:05 PM EDT - 1 year ago

TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs

Mar 27, 2024, 4:01 PM EDT - 1 year ago

TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs

TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (I

Mar 25, 2024, 9:01 AM EDT - 1 year ago

TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (I

TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Mar 22, 2024, 3:11 PM EDT - 1 year ago

TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Mar 20, 2024, 12:00 PM EDT - 1 year ago

TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

TFF Pharmaceuticals Announces Update on Clinical Programs

Mar 20, 2024, 9:03 AM EDT - 1 year ago

TFF Pharmaceuticals Announces Update on Clinical Programs

TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024

Mar 14, 2024, 4:47 PM EDT - 1 year ago

TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024

TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conference

Jan 24, 2024, 8:00 AM EST - 1 year ago

TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conference

TFF Pharmaceuticals Announces Acceptance of Late-Breaking Abstract for Presentation at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting

Jan 9, 2024, 8:00 AM EST - 1 year ago

TFF Pharmaceuticals Announces Acceptance of Late-Breaking Abstract for Presentation at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting

TFF Pharmaceuticals Announces Positive Initial Data from Ongoing Phase 2 Trials of TFF VORI and TFF TAC

Dec 19, 2023, 6:00 AM EST - 1 year ago

TFF Pharmaceuticals Announces Positive Initial Data from Ongoing Phase 2 Trials of TFF VORI and TFF TAC

TFF Pharmaceuticals to Host Webcast and Conference to Review Initial Data from the Ongoing Phase 2 Trials of TFF VORI and TFF TAC

Dec 18, 2023, 4:01 PM EST - 1 year ago

TFF Pharmaceuticals to Host Webcast and Conference to Review Initial Data from the Ongoing Phase 2 Trials of TFF VORI and TFF TAC

TFF Pharmaceuticals Announces Reverse Stock Split

Dec 15, 2023, 7:00 AM EST - 1 year ago

TFF Pharmaceuticals Announces Reverse Stock Split

TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors

Dec 13, 2023, 8:00 AM EST - 1 year ago

TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors

TFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directors

Nov 30, 2023, 8:00 AM EST - 1 year ago

TFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directors

TFF Pharmaceuticals Appoints Michael Patane, Ph.D., to Board of Directors

Nov 30, 2023, 8:00 AM EST - 1 year ago

TFF Pharmaceuticals Appoints Michael Patane, Ph.D., to Board of Directors

TFF Pharmaceuticals to Participate in the 2023 Benchmark Discovery One-on-One Investor Conference – December 7, 2023

Nov 27, 2023, 7:00 AM EST - 1 year ago

TFF Pharmaceuticals to Participate in the 2023 Benchmark Discovery One-on-One Investor Conference – December 7, 2023

TFF Pharmaceuticals, Inc. (TFFP) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 8:23 PM EST - 1 year ago

TFF Pharmaceuticals, Inc. (TFFP) Q3 2023 Earnings Call Transcript

TFF Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Nov 14, 2023, 4:05 PM EST - 1 year ago

TFF Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

TFF Pharmaceuticals Announces Publication of Data Demonstrating Feasibility of Intranasal Delivery of Monoclonal Antibodies with Thin Film Freezing

Nov 8, 2023, 4:05 PM EST - 1 year ago

TFF Pharmaceuticals Announces Publication of Data Demonstrating Feasibility of Intranasal Delivery of Monoclonal Antibodies with Thin Film Freezing

TFF Pharmaceuticals to Hold Third Quarter 2023 Financial and Business Results Conference Call on November 14, 2023

Nov 7, 2023, 4:05 PM EST - 1 year ago

TFF Pharmaceuticals to Hold Third Quarter 2023 Financial and Business Results Conference Call on November 14, 2023

TFF Pharmaceuticals Congratulates our Scientific Advisory Board Member, Drew Weissman, M.D., Ph.D., for Receiving the Nobel Prize in Physiology or Medicine for his Pioneering Work Enabling the Development of mRNA COVID-19 Vaccines

Oct 2, 2023, 5:00 PM EDT - 1 year ago

TFF Pharmaceuticals Congratulates our Scientific Advisory Board Member, Drew Weissman, M.D., Ph.D., for Receiving the Nobel Prize in Physiology or Medicine for his Pioneering Work Enabling the Development of mRNA COVID-19 Vaccines

TFF Pharmaceuticals to Participate in Upcoming Investor Conferences

Sep 28, 2023, 4:29 PM EDT - 1 year ago

TFF Pharmaceuticals to Participate in Upcoming Investor Conferences

TFF Pharmaceuticals to Participate in the H.C. Wainwright 25th Annual Global Investment Conference – September 11-13, 2023

Aug 23, 2023, 7:00 AM EDT - 1 year ago

TFF Pharmaceuticals to Participate in the H.C. Wainwright 25th Annual Global Investment Conference – September 11-13, 2023

TFF Pharmaceuticals Announces Closing of $5.7 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option

Aug 17, 2023, 4:01 PM EDT - 1 year ago

TFF Pharmaceuticals Announces Closing of $5.7 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option

TFF Pharmaceuticals, Inc. (TFFP) Q2 2023 Earnings Call Transcript

Aug 15, 2023, 4:51 PM EDT - 1 year ago

TFF Pharmaceuticals, Inc. (TFFP) Q2 2023 Earnings Call Transcript

TFF Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Aug 15, 2023, 6:05 AM EDT - 2 years ago

TFF Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

TFF Pharmaceuticals Prices $5 Million Public Offering of Common Stock

Aug 15, 2023, 6:00 AM EDT - 2 years ago

TFF Pharmaceuticals Prices $5 Million Public Offering of Common Stock

TFF Pharmaceuticals Announces Proposed Public Offering of Common Stock

Aug 14, 2023, 4:01 PM EDT - 2 years ago

TFF Pharmaceuticals Announces Proposed Public Offering of Common Stock

TFF Pharmaceuticals to Hold Second Quarter 2023 Financial and Business Results Conference Call on August 15, 2023

Aug 9, 2023, 8:30 AM EDT - 2 years ago

TFF Pharmaceuticals to Hold Second Quarter 2023 Financial and Business Results Conference Call on August 15, 2023

TFF Pharmaceuticals Inc. and Uniphar Durbin Ireland Ltd. Announce the Opening of an Expanded Access Program for Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Pulmonary Aspergillosis and Other Voriconazole Responsive Fungal Pulmonary Infec

Jul 31, 2023, 7:00 AM EDT - 2 years ago

TFF Pharmaceuticals Inc. and Uniphar Durbin Ireland Ltd. Announce the Opening of an Expanded Access Program for Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Pulmonary Aspergillosis and Other Voriconazole Responsive Fungal Pulmonary Infec

TFF Pharmaceuticals Awarded $2.97 Million to Develop Universal Influenza Vaccine

Jun 26, 2023, 7:00 AM EDT - 2 years ago

TFF Pharmaceuticals Awarded $2.97 Million to Develop Universal Influenza Vaccine

TFF Pharmaceuticals to Participate in the 2023 Jefferies Healthcare Conference

May 23, 2023, 4:05 PM EDT - 2 years ago

TFF Pharmaceuticals to Participate in the 2023 Jefferies Healthcare Conference

TFF Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results

May 11, 2023, 4:05 PM EDT - 2 years ago

TFF Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results

TFF Pharmaceuticals Enters into CRADA with the National Institute of Environmental Health Sciences to Develop Dry Powder Formulations of Hyaluronan to Prevent and Treat Respiratory Diseases

May 4, 2023, 8:00 AM EDT - 2 years ago

TFF Pharmaceuticals Enters into CRADA with the National Institute of Environmental Health Sciences to Develop Dry Powder Formulations of Hyaluronan to Prevent and Treat Respiratory Diseases

TFF Pharmaceuticals Receives Additional Funding from Leidos to Advance Next-Generation Personalized Protective Biosystems under the DARPA PPB Program

May 1, 2023, 7:00 AM EDT - 2 years ago

TFF Pharmaceuticals Receives Additional Funding from Leidos to Advance Next-Generation Personalized Protective Biosystems under the DARPA PPB Program

TFF Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results

Mar 7, 2023, 4:15 PM EST - 2 years ago

TFF Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results

A_Aron1990
A_Aron1990 May. 21 at 12:34 PM
$TFFP for fucks sake how long this shit take to be removed
1 · Reply
frenulum1
frenulum1 Apr. 23 at 7:03 PM
$TFFP imagine being a promoter of this stock?
0 · Reply
YesterdayRecords
YesterdayRecords Apr. 2 at 4:53 AM
$TFFP How much longer will this be locked up? I’d like to sell and be done
0 · Reply
G1992
G1992 Feb. 3 at 4:42 PM
$TFFP sup with this trash thought we had to hear about vote count last week
1 · Reply
Faroose
Faroose Jan. 25 at 1:20 PM
$FMST breaking past key technical resistance, high RVOL, low float, and insider buying making it unstoppable $TFFP moving $FLYE soaring $SVUHF climbing
1 · Reply
Pumptie
Pumptie Jan. 20 at 5:13 PM
$ABVE bottom chart low floats have been killer. $NUKK was insane. $TFFP WW $HMR ww $TNXP was huge call out. Great play again This is next. Looking for 100% to 200% easy
2 · Reply
Pumptie
Pumptie Jan. 20 at 5:02 PM
$ABVE this has huge potential all over it. Alot of whales taking about it. Im in. $TFFP going MSTR GOING TO 500
0 · Reply
A_Aron1990
A_Aron1990 Jan. 17 at 1:36 PM
$TFFP just go away you POS
0 · Reply
YesterdayRecords
YesterdayRecords Dec. 26 at 10:08 PM
Man, I’m sick of having to keep seeing this train wreck… $TFFP is now like that one shitty ex- who just lingers around not going away…
0 · Reply
Winner4Ever
Winner4Ever Dec. 26 at 8:13 PM
$TFFP what is going on?
0 · Reply
A_Aron1990
A_Aron1990 Dec. 19 at 1:49 PM
$TFFP close this POS out already
0 · Reply
A_Aron1990
A_Aron1990 Dec. 17 at 12:14 PM
$TFFP how long until this crap is removed from my investments im tired of seein it thats the real question
0 · Reply
Takeiteasy30
Takeiteasy30 Dec. 16 at 12:44 PM
$TFFP
0 · Reply
Takeiteasy30
Takeiteasy30 Dec. 16 at 12:44 PM
$TFFP
0 · Reply
Inzi
Inzi Dec. 13 at 11:00 PM
$TFFP So if I have some shares in this, can I not sell them on T212?
1 · Reply
momoneyinfla
momoneyinfla Dec. 13 at 3:47 PM
$TFFP how could you all have not read the articles from November? They said they were winding down and filing bankruptcy 😂
1 · Reply
JackRo
JackRo Dec. 13 at 3:13 PM
Why $TFFP is not trading today? any information?
1 · Reply
dbr_island
dbr_island Dec. 13 at 3:04 PM
$LDTC looks like it wants $2+ $LAES $LOOP $TFFP $TRUG
0 · Reply
Deadpresidentz
Deadpresidentz Dec. 13 at 2:58 PM
$LOOP $TFFP $TRUG $LAES $LDTC
0 · Reply
dbr_island
dbr_island Dec. 13 at 2:25 PM
$TRUG another winner 💰✅ And the market hasn’t even opened yet FGL is my next MONSTER in the making $LAES $LOOP $TFFP $LDTC let’s get it
1 · Reply